Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
C-MER Medical HoldingsHKSE:03309 -0.58%83 ROA % is 3.67% as of Dec. 2025, which is 25% above its 10-year median of 2.94. GuruFocus rates HKSE:03309 with a GF Score™ of 83/100 and a GF Value™ of HK$2.77 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 685 Healthcare Providers & Services companies, C-MER Medical Holdings ranks better than 58.98% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. C-MER Medical Holdings's annualizedNet Income for the quarter that ended in Dec. 2025 was HK$101 Mil.
C-MER Medical Holdings's average Total Assets over the quarter that ended in Dec. 2025 was HK$2,748 Mil. Therefore, C-MER Medical Holdings's annualized ROA % for the quarter that ended in Dec. 2025 was 3.67%.
The historical rank and industry rank for C-MER Medical Holdings's ROA % or its related term are showing as below:
HKSE:03309'
s ROA % Range Over the Past 10 Years
Min: -4.94 Med: 2.94 Max: 35.93
Current: 3.66
During the past 12 years, C-MER Medical Holdings's highest ROA % was 35.93%. The lowest was -4.94%. And the median was 2.94%.
HKSE:03309's ROA % is ranked better than 58.98% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 1.95
vs HKSE:03309: 3.66
C-MER Medical Holdings (HKSE:03309) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, C-MER Medical Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
C-MER Medical Holdings ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, C-MER Medical Holdings's ROA % distribution charts can be found below:
* The bar in red indicates where C-MER Medical Holdings's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
C-MER Medical Holdings (HKSE:03309) has a ROA % of 3.67% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on C-MER Medical Holdings and its competitors. This is 25% above median its historical median of 2.94. According to the industry distribution chart, C-MER Medical Holdings ranks #281 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 41%.
Is C-MER Medical Holdings' ROA % too high?
C-MER Medical Holdings' current ROA % of 3.67% is 25% above median its 10-year median of 2.94. The Healthcare Providers & Services industry median ROA % is 1.95. C-MER Medical Holdings' value of 3.67% is 88.2% above this industry median. Based on the distribution chart, C-MER Medical Holdings ranks #281 out of 685 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, C-MER Medical Holdings has a GF Score™ of 83/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does C-MER Medical Holdings' ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, C-MER Medical Holdings ranks #281 out of 685 companies for ROA %. This puts C-MER Medical Holdings in the upper half of its industry. The industry median ROA % is 1.95. C-MER Medical Holdings' value of 3.67% is 88.2% above this benchmark. While the company's 10-year median is 2.94 vs. the industry median of 1.95, C-MER Medical Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.95, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. C-MER Medical Holdings's current ROA % of 3.67% is 88.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on C-MER Medical Holdings and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. C-MER Medical Holdings's current ROA % is 3.67%, which is 25% above median its own 10-year median of 2.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is C-MER Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, C-MER Medical Holdings (HKSE:03309) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.77, compared to a current price of HK$0.86 — trading 69.1% below its estimated fair value. The current ROA % is 3.67%, which is 25% above median its 10-year median of 2.94 and 88.2% above the Healthcare Providers & Services industry median of 1.95. C-MER Medical Holdings' overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For C-MER Medical Holdings (HKSE:03309), the current ROA % is 3.67% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is C-MER Medical Holdings (HKSE:03309) Overvalued in 2026?
Based on GuruFocus' analysis, C-MER Medical Holdings stock appears to be undervalued.
The current stock price of HK$0.86 is trading 69.1% below its estimated GF Value™ of HK$2.77.
GuruFocus considers C-MER Medical Holdings to be Possible Value Trap.
Key valuation signals for HKSE:03309:
ROA %: 3.67% (25% above median its 10-year median of 2.94)
GF Value™: HK$2.77 vs. price of HK$0.86 (69.1% below fair value)
Industry Position: 88.2% above the Healthcare Providers & Services median (#281 of 685)
No single metric tells the full story. See the HKSE:03309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
C-MER Medical Holdings Ltd is a ophthalmic medical chain group in Hong Kong and the Greater Bay Area. With ophthalmology as its core, it has gradually expanded its business scope to different specialist services. The company through its subsidiaries are principally engaged in the provision of ophthalmic, dental and other medical services, sales of vision aid products and sales of medical consumables in Hong Kong and Mainland China. Geographically, the company generates revenue from Mailand China, and Hong Kong, with the majority of revenue generated from Mainland China.
83GF Score
Get the complete analysis for HKSE:03309
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:03309 has been successfully added to your 
